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Apelin is the peptidic ligand for the G-protein-coupled receptor APJ. The apelin-APJ system is important in
cardiovascular regulation, ﬂuid homeostasis, and angiogenesis, among other roles. In this study, we investigate
interactions between apelin and membrane-mimetic micelles of the detergents sodium dodecyl sulfate (SDS),
dodecylphosphocholine (DPC), and 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] (LPPG).
Far-ultraviolet circular dichroism spectropolarimetry and diffusion-ordered spectroscopy indicate that apelin
peptides bind to micelles of the anionic detergents SDS and LPPG much more favorably than to zwitterionic
DPC micelles. Nuclear magnetic resonance spectroscopy allowed full characterization of the interactions of
apelin-17 with SDS micelles. Titration with paramagnetic agents and structural determination of apelin-17 in
SDS indicate that R6-K12 is highly structured, with R6-L9 directly interacting with headgroups of the
micelle. Type I  -turns are initiated between R6 and L9, and a well-deﬁned type IV  -turn is initiated at S10.
Furthermore, binding of apelin-17 to SDS micelles causes structuring of M15-F17, with no evidence for
direct binding of this region to the micelles. These results are placed into the context of the membrane catalysis
hypothesis for peptide-receptor binding, and a hypothetical mechanism of APJ binding and activation by
apelin is advanced.
Introduction
The apelin peptides activate the class A rhodopsin-like
G-protein-coupled receptor (GPCR) named APJ.1 Apelin-APJ
signaling has been demonstrated within the cardiovascular
system, central nervous system, and adipoinsular axis (as
previously reviewed2), among other physiological settings.
Apelin is an extremely potent inotropic agent, increasing muscle
contractility with a half-maximal effective concentration of ∼33
pmol/L in rat heart.3 Upregulation of apelin is observed in
conjunction with an elevated body mass index,4 and plasma
levels of apelin are increased during heart failure.5 Furthermore,
apelin inhibits human immunodeﬁciency virus fusion to host
cells,6 and apelin has been shown to induce angiogenesis during
tumor formation.7,8 As a whole, these functions have made the
apelin-APJ system popular as a proposed therapeutic target.2,9,10
Apelin is produced as a 77 amino acid preproprotein that is
cleaved into a variety of bioactive forms from 13 to 36 residues
in length, each of which retain the C-terminus of the precursor.11
The 12 C-terminal residues of apelin constitute the core region
essential for apelin function.12-14 Our recent NMR studies on
apelin-17 suggest that this core region is only moderately
structured in solution at physiological temperature, but that
binding to APJ may lead to more deﬁned structuring.15
Sargent and Schwyzer16 ﬁrst formulated the “membrane
catalysis” hypothesis, stating that a small peptide ﬁrst interacts
with the target cell plasma membrane before binding to and
activating its target receptor. The membrane is proposed to act
as a receptor-ligand catalyst by increasing the local concentra-
tion of the ligand, improving the probability of diffusional
collision between the receptor and ligand, and/or by inducing a
conformational change in the peptide to increase the receptor-
binding energetics. This is supported by the fact that many
peptide hormones bind to membranes or micelles17-21 and in
some cases have been shown to adopt a speciﬁc structure when
bound to the membrane.22-24 A striking example is calcitonin,
a peptide hormone involved in calcium homeostasis.22 In the
presence of sodium dodecyl sulfate (SDS) micelles, calcitonin
assumes an R-helical structure while being unstructured in
solution. Furthermore, deletion of the critical F16 residue
disrupts in parallel both the induction of the R-helical structure
and the function of calcitonin.
Results of this nature, in the context of the membrane catalysis
model, provide strong incentive to investigate the potential
interactions of apelin with lipids. Herein, we use circular
dichroism (CD) spectropolarimetry and pulsed ﬁeld gradient
NMR diffusion measurements to probe interactions of apelin-
17 and apelin-12 with SDS micelles, dodecylphosphocholine
(DPC) micelles, and 1-palmitoyl-2-hydroxy-sn-glycero-3-[phos-
pho-rac-(1-glycerol)] (LPPG) micelles. An NMR spectroscopy
based structure of apelin-17 bound to SDS micelles is also
presented, and paramagnetic titration gives an overview of the
topology of the apelin-17/SDS micelle complex. Finally, the
signiﬁcance of these ﬁndings in relation to the membrane
catalysis model is discussed.
Materials and Methods
Materials. LPPG was purchased from Avanti Polar lipids
(Alabaster, AL). Deuterium oxide (D2O; 99.8 atom % D), SDS-
d25, DPC, DPC-d38, and D2O containing 1% (w/w) sodium 2,2-
dimethyl-2-silapentane-5-sulfonate (DSS) were obtained from
C/D/N Isotopes (Pointe-Claire, QC, Canada). Fmoc-protected
amino acids and coupling reagents were obtained from AAPPTec
(Louisville, KY). All other chemicals were obtained at biotech-
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grade, as appropriate, from Sigma-Aldrich (Oakville, ON,
Canada).
Peptide Synthesis and Puriﬁcation. Apelin-17 (H2N-
KFRRQRPRLSHKGPMPF-COO-) and apelin-12 (H2N-
RPRLSHKGPMPF-COO-) were produced and puriﬁed in
multimilligram quantities using previous procedures.15 Peptide
identities were conﬁrmed using matrix-assisted laser desorption
ionization mass spectrometry and quantitative amino acid
analysis (Hospital for Sick Children, Toronto, ON, Canada).
CD Spectropolarimetry. Far-ultraviolet CD spectra of ape-
lin-17 and apelin-12 were recorded at 35 °C using a Jasco J-810
spectropolarimeter (Easton, MD). Solutions of apelin peptides
(apelin-12, 55.2 ( 0.7 µM; apelin-17, 64.5 ( 5.2 µM; exact
concentration determined by quantitative amino acid analysis;
Hospital for Sick Children) were prepared from a single stock
solution. For each apelin peptide, samples were prepared with
no lipid added and 16 mM SDS, 19 mM DPC, or 38 mM LPPG
in 20 mM sodium phosphate adjusted to pH 7.00 ( 0.05. Spectra
were acquired from 260 nm downward (1 nm steps), with
reliable ellipticity values observed at >190 nm based on
spectropolarimeter photomultiplier tube voltages, in 0.5 mm path
length quartz cuvettes (Hellma, Mu ¨llheim, Germany). All
measurements were collected in triplicate. Machine data were
converted to the mean residue ellipticity, [θ], averaged over all
trials, blank subtracted, and subjected to sliding-window averag-
ing over 3 nm stretches so that [θ] reported at a given
wavelength (λ)i s
Finally, each spectrum was baseline adjusted by subtracting the
average ellipticity value over 250-260 nm.
Paramagnetic Relaxation Measurements. Three identical
NMR samples were prepared with 1 mM apelin-17 in a 90%
H2O/10% D2O mixture with 20 mM Na+CD3COO-,1m M
NaN3, 90 mM SDS, and 1 mM DSS. Each sample was titrated
with MnCl2, 5-doxylstearic acid (5-DSA), or 16-doxylstearic
acid (16-DSA) up to a maximum of 8 mM paramagnetic agent
at 35 °C. Titrations were halted when a ∼50% reduction in the
intensities of ∼50% of the peaks was observed using 1H-1H
total correlation spectroscopy (TOCSY) relative to a reference
spectrum. For each residue, the intensities of one or two
nonoverlapped cross-peaks were measured (depending on the
availability of nonoverlapped peaks). Titration of 16-DSA was
at 800 MHz using a Varian INOVA spectrometer (Palo Alto,
CA) at the National High Field Nuclear Magnetic Resonance
Centre (NANUC; Edmonton, AB, Canada), while both Mn2+
and 5-DSA were titrated at 700 MHz on a Bruker Avance III
spectrometer (Milton, ON, Canada) at the National Research
Council Institute for Marine Biosciences (NRC-IMB; Halifax,
NS, Canada). Both spectrometers are equipped with cryogeni-
cally cooled triple-resonance probes. NMR data were processed
using NMRPipe25 and peak intensities measured with a Gaussian
line shape in Sparky 3 (T. D. Goddard and D. G. Kneller,
University of California, San Francisco).
Diffusion-Ordered Spectroscopy. Four samples of apelin-
17 were prepared for DOSY experiments with 1 mM apelin-
17, 20 mM Na+CD3COO-,1m MN a N 3, and 1 mM DSS in
90% H2O/10% D2O, with three samples containing 81 mM SDS-
d25, 94 mM DPC-d25, or 187 mM LPPG. Identical samples were
also prepared without apelin. Detergent concentrations were
chosen to give ∼1.25:1 micelle:peptide ratios. Sample pH values
were adjusted to 5.00 ( 0.05 using DCl and NaOD. DOSY
spectra were acquired at 35 °C using a stimulated echo sequence
with bipolar gradients26 and a longitudinal eddy current decay
of 5 ms at 500 MHz on a Bruker Avance II spectrometer with
a TXI probe at the Nuclear Magnetic Resonance Research
Resource (NMR3; Halifax, NS). Susceptibility-matched tubes
(Shegemi, Allison Park, PA) were used to minimize diffusion
artifacts due to gradient nonlinearity or convection currents.
Signal attenuation at the maximum gradient strength was
adjusted to be 95%, with 32 increments collected in the diffusion
dimension with the gradient strength ranging from 1.7 to 32.0
G/cm. DOSY experiments were performed in triplicate.
Diffusion coefﬁcients for apelin-17 in each condition along-
side those of each micelle in the absence of apelin were obtained
using the relaxation module of Topspin 2.1 (Bruker). Topspin
uses an iterative procedure to ﬁt the equation
to the data, where I and I0 are the peak intensities when the
experiment is performed with and without a gradient, respec-
tively, D is the translational diffusion coefﬁcient, γ is the
gyromagnetic ratio, and δ and ∆ are the gradient duration and
diffusion time, respectively. Due to what appeared to be a
consistent artifact, the ﬁrst (lowest gradient strength) increment
of each experiment was discarded, and 31 diffusion time points
were used for ﬁtting. For apelin-17 and each micelle, the
translational diffusion coefﬁcient (D) was calculated using three
separate 1H NMR peaks for each spectral data set (i.e., nine
measurements per condition), and the values were averaged to
give a ﬁnal value of D with associated standard error.
To determine the fraction of apelin-17 bound to each micelle,
a fast two-site exchange model27 was used:
where Dobsd is the observed diffusion coefﬁcient of apelin-17
in the presence of micelles, fb and Db are the fraction of apelin-
17 bound to micelles and the diffusion coefﬁcient of the
micelles, respectively, and Df is the translational diffusion
coefﬁcient of free apelin. We made the assumption that the
diffusion coefﬁcient of a micelle, Db, does not differ signiﬁcantly
with the presence or absence of apelin-17. The viscosity of each
solution was not measured. Instead, the expected effect of the
presence of micelles on the value of Df was estimated via the
following expression for small molecules obstructed by spherical
particles:28
where Df
0 is the measured diffusion coefﬁcient of apelin-17 in
water and φ is the volume fraction of lipids in the sample, which
can be estimated by using the weight fraction.28 Using eqs 3
and 4 and the values of D obtained using Topspin, the fraction
of apelin-17 bound to each micelle was estimated.
Sequential Assignment of Apelin-17 in SDS and DPC
Micelles. Two 600 µL NMR samples were made with 20 mM
Na+CD3COO-,1m MN a N 3, 1 mM DSS, 0.5 mM apelin-17,
and either 81 mM SDS-d25 or 94 mM DPC-d38. 1H-1H TOCSY
(80 ms mixing time), 1H-1H nuclear Overhauser effect spec-
troscopy (NOESY; 350 ms mixing time), gradient-enhanced
natural abundance 1H-13C heteronuclear single-quantum coher-
[θ] )
1/4[θ]λ-1 +
1/2[θ]λ +
1/4[θ]λ+1 (1)
I ) I0 exp[-Dγ
2g
2δ
2(∆ - δ/3)] (2)
Dobsd ) fbDb + (1 - fb)Df (3)
Df ) Df
0/(1 + φ/2) (4)
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at 700 MHz (NRC-IMB Avance III) with a TCI cryoprobe at
35 °C. NMR data were processed using NMRPipe25 and
manually assigned in Sparky 3 (T. D. Goddard and D. G.
Kneller, University of California, San Francisco). Secondary
chemical shifts, ∆δ ) δ(obsd) - δ(random coil),29-31 of the
HR,H  ,C R, and C  nuclei were calculated using the random
coil chemical shifts of Wishart and co-workers.32
Structural Calculations of Apelin-17 Bound to SDS
Micelles. XPLOR-NIH version 2.1833 was used for ﬁnal
structure determination of apelin-17 in the presence of SDS
micelles using the methods of NOE intensity calculation and
reﬁnement detailed by Langelaan and co-workers.15 An en-
semble of 200 structures was generated, with the 80 lowest
energy structures retained as the ﬁnal ensemble. The LSQKAB
software of the CCP4 suite34 was used to iteratively superpose
the ensemble over 2-17-residue stretches while an in-house
tcl/tk script was used to calculate the root mean squared
deviation (rmsd) of the backbone atoms within the superposed
region (using a previously developed iterative superposition
protocol35,36). Lastly, the ensemble was analyzed (i) using
Procheck-NMR to determine the proportion of residues in
favored, allowed, generously allowed, and disallowed regions
of the Ramachandran plot,37 (ii) with Promotif-NMR to deter-
mine the number, type, and position of  -turns present in the
ensemble,38 and (iii) using an in-house tcl/Tk script to calculate
both the deviation and order parameter (S, as deﬁned by Hyberts
et al.39)o ft h eφ and ψ dihedral angles. All chemical shift data
for apelin-17 with SDS and DPC micelles as well as the ﬁnal
structural ensemble for apelin-17 with SDS micelles have been
deposited to the Biological Magnetic Resonance Bank40 using
SMSDep (accession numbers 20082 and 16275 for apelin-17
with SDS and DPC micelles, respectively).
Results and Discussion
CD Spectropolarimetry of Apelin-12 and Apelin-17. The
far-ultraviolet (far-UV) CD spectra from 260 to 190 nm of both
apelin-12 and apelin-17 in buffer and in the presence of SDS,
DPC, or LPPG micelles are shown in Figure 1. For any given
condition, the CD spectra for both apelin-12 and apelin-17 have
similar features. As we have previously described,15 the spectra
for both apelin-12 and apelin-17 in buffer at 35 °C are random
coil41 in nature. This primarily random coil spectrum is
convoluted with positive bands at 195 and 218 nm, most likely
attributable to the 1B and 1La transitions42,43 of the C-terminal
phenylalanine.15 For both apelin-12 and apelin-17, DPC micelles
do not strongly perturb the CD spectrum relative to the buffer
(Figure 1). In contrast, dramatic spectral changes occur with
both apelin isoforms in the presence of either SDS or LPPG
micelles. The CD spectra with these micelles present are
convoluted by an R-helix-like band pattern (difference spectra
in Figure 1), which may be attributed either to formation of the
R-helical secondary structure41 or to the formation of  -turns.44,45
Although the main trends observed in the CD spectra of
apelin-12 and apelin-17 are identical, there are a few minor
differences between isoforms. In the presence of DPC micelles,
a slightly larger deviation from buffer conditions is observed
for apelin-12 than for apelin-17. Also, the CD spectra of apelin-
17 in the presence of LPPG and SDS are nearly identical, while
for apelin-12 the CD spectrum in LPPG shows a larger deviation
from buffer conditions in comparison to that in SDS (Figure
1). Despite these slight differences, the underlying trends in the
CD spectra of apelin-12 and apelin-17 are the same, with DPC
micelles causing little to no change in the spectra relative to
the buffer versus SDS and LPPG, which produce increasing
amounts of perturbation of the CD spectrum relative to the
buffer. A similar trend was observed with DPC and SDS
micelles for apelin-13, pyroglutamate-apelin-13, and apelin-
36 (Bebbington and Rainey, unpublished), suggesting that all
of these apelin peptides undergo similar structural changes in
the presence of anionic micelles.
Diffusion Coefﬁcient Determination. Translational diffusion
coefﬁcients (D) were measured for SDS, DPC, and LPPG
micelles, for apelin-17 in buffer, and for apelin-17 in the
presence of each micelle (Table 1). Reported literature diffusion
values (DOSY determined) are 1.2 × 10-10 m2/s for DPC
micelles,46 9.5 × 10-11 m2/s for SDS micelles,47 and 6.62 ×
10-11 m2/s for LPPG micelles.48 Once adjusted for temperature
and viscosity using literature viscosity values49 to match our
experimental conditions, these measurements become 1.35 ×
10-10, 1.47 × 10-10, and 8.49 × 10-11 m2/s, respectively.
Although our reported D values are slightly higher, the
agreement with previous D values is reasonable. Discrepancies
may be due to effects of the different temperature and buffer
conditions in our study upon the aggregation number of the
micelles. In particular, the aggregation number of the micelles
decreases with increasing temperature,50 and our study was at
35 °C, while the reported values of D for SDS and LPPG were
at 25 °C and that for DPC was at 30 °C. Also, the observed D
for a micelle is often an overestimate due to contributions from
monomeric detergent remaining in solution. Under buffer
conditions, however, the critical micelle concentrations of the
detergents are lowered, and for each micelle employed herein,
the contribution of monomeric detergent to D was minor since
only ∼5%, ∼1%, and ∼0.03% of SDS, DPC, and LPPG are
estimated to be present as monomers (based upon critical micelle
concentration values of ∼4 mM,51 1.1 mM,52 and 0.06 mM52
for SDS, DPC, and LPPG, respectively).
Upon determination of D, the fb of apelin-17 with each micelle
was calculated using eq 3, indicating relatively weak binding
of apelin-17 to DPC micelles and strong binding with both SDS
Figure 1. Far-ultraviolet circular dichroism spectra of (A) apelin-12
and (B) apelin-17 in buffer, SDS micelles, DPC micelles, and LPPG
micelles alongside the difference spectrum between LPPG and the
buffer. Spectropolarimetry (sliding-window (eq 1) averaged blank-
subtracted averages of three replicates) was performed at 35 °Ci n2 0
mM phosphate buffer at pH 7.00 ( 0.05.
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spectropolarimetry results. This interaction is somewhat predict-
able due to the strongly cationic nature of apelin-17, which
contains eight basic residues to facilitate its interaction with
anionic headgroups. However, without experimental demonstra-
tion such as this, it is not necessarily predictable that a peptide
as hydrophilic as apelin-17 will interact so strongly with
detergent micelles in solution.
NMR Assignment and Secondary Chemical Shifts. Nearly
complete assignment of 1H, 13C, and 15N was obtained for apelin-
17 (Table S1 in the Supporting Information) in the presence of
both SDS and DPC micelles using standard methods,53 allowing
comparison of ∆δ32 for HR,C R,H  , and C  nuclei in the presence
of SDS and DPC micelles to those in buffer that we previously
reported15 (Figure 2). For both HR and C , there is no clear
relationship between the value of the secondary chemical shift
and the condition used. However, these ∆δ values are signiﬁ-
cantly different in the presence of SDS micelles compared to
those in either the buffer or DPC conditions over K1-K12,
while ∆δ values in the C-terminal of apelin-17 show little
perturbation in the presence of micelles. The large changes in
∆δ values of CR and H  atoms in the presence of SDS suggest
that apelin-17 is binding to the SDS micelles rather than forming
a different, canonical secondary structure since HR and C  would
also be expected to have a consistent ∆δ perturbation with
secondary structure formation. Determination of the effect of
LPPG micelles on ∆δ values was not possible as deuterated
LPPG is not available, making spectral assignment infeasible
for apelin without isotopic enrichment.
In all cases, apelin-17 showed a single, predominant set of
chemical shifts at 35 °C with D values between those of free
apelin and those of each detergent micelle indicative of fast
exchange on the NMR time scale between the free and bound
states (i.e., submillisecond exchange54). Fast exchange may be
less relevant in the case of LPPG, given the almost 100%
binding stoichiometry; however, it is certainly feasible that
similar transient binding is taking place under an equilibrium
favored further toward the bound state than in the SDS and
DPC cases. Conformational sampling of apelin-17 was also
evident in the NMR data, as we previously observed in buffer,15
with a minor conformation in the P14-F17 region <10% as
populated as the major one. Only the major conformer was
sequentially assigned as there were few NOE contacts in the
minor conformer. CD spectropolarimetry, DOSY, and chemical
shift analysis therefore clearly demonstrate that the apelin
peptides bind weakly and transiently to zwitterionic DPC
micelles but bind favorably to anionic SDS and LPPG micelles.
Paramagnetic Relaxation Enhancement. To determine the
region of apelin-17 that is interacting with anionic micelles,
paramagnetic relaxation enhancement NMR spectroscopy ex-
periments were used. The 1H-1H TOCSY peak attenuation of
apelin-17 in SDS micelles with various concentrations of
5-DSA, 16-DSA, or Mn2+ is summarized in Figure 3. These
reagents would be expected to attenuate the NMR signals for
nuclei in the tailgroup core of the micelle (16-DSA), just below
the anionic headgroup (5-DSA), or readily accessible to solution
(Mn2+). For both 5-DSA and 16-DSA, there is no clear trend
of peak attenuation over apelin-17, even at relatively high
concentrations of paramagnetic agent, suggesting that apelin-
17 does not associate in the hydrophobic core of the micelles
or just below the headgroups of SDS (Figure 3A). In contrast,
TABLE 1: Fraction of Apelin-17 Bound (fb) to the Indicated Micelle Types as Determined through Diffusion-Ordered NMR
Spectroscopy Methodsa
component ∆ (ms) δ (ms) Dobsd (m2/s) fb
SDS micelles 60 6.4 1.7 × 10-10 ( 1.6 × 10-12 N/A
DPC micelles 60 6.4 1.8 × 10-10 ( 1.6 × 10-12 N/A
LPPG micelles 85 7.0 9.6 × 10-11 ( 2.8 × 10-13 N/A
apelin-17 55 4.4 3.6 × 10-10 ( 3.4 × 10-12 N/A
apelin-17 with SDS micelles 65 5.2 2.0 × 10-10 ( 1.2 × 10-11 82 ( 5%
apelin-17 with DPC micelles 60 5.2 2.8 × 10-10 ( 3.4 × 10-12 46 ( 5%
apelin-17 with LPPG micelles 70 6.6 1.0 × 10-10 ( 1.2 × 10-12 98 ( 5%
a Topspin (Bruker) was used to determine the diffusion coefﬁcients (Dobsd) of three peaks of the component of interest for three replicate
experiments to give an average Dobsd with associated average deviation. Assuming two-state fast exchange for apelin-17, fb was estimated using
eqs 3 and 4. The experimental settings for the diffusion time (∆) and gradient duration (δ) for each experiment are indicated; pulsed ﬁeld
gradients were varied from 1.7 to 32.0 G/cm.
Figure 2. Apelin-17 secondary chemical shifts (∆δ ) δ(obsd) -
δ(random coil)29) for HR,C R,H  , and C  (the prime symbol denotes a
degenerate shift) at 35 °C in buffer15 (20 mM CD3COO-, pH 5.00 (
0.05), SDS micelles, and DPC micelles. Horizontal lines show the ∆δ
cutoff signiﬁcant for secondary structuring31 (note that CR and C  for
Pro have identiﬁed signiﬁcance ranges of (4 ppm).
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of apelin-17 by Mn2+. At 0.25 mM Mn2+, many residues of
apelin-17 show large attenuation of peak intensity, notably at
the C-terminal region (Figure 3B). After titration with 1 mM
Mn2+, only K1 and R6-L9 have an observable signal, indicating
that these residues of apelin-17 interact most strongly with SDS
micelles since they are partially shielded from the effects of
Mn2+. However, even these residues are largely attenuated by
Mn2+, indicating that although they interact with the micelle,
they are still partially solvent exposed and very near the micelle
surface, as supported by the lack of peak attenuation induced
by 5-DSA or 16-DSA.
Structure of Apelin-17 in SDS Micelles. In total, 522 unique
NOESY contacts were observed (with each NOE being con-
sidered from the perspective of each nucleus of the spin pair).
This is an almost 2-fold increase in observed NOE contacts in
comparison to those of apelin-17 in buffer at 35 °C (285
restraints15), indicating a dramatic increase in structuring of
apelin-17 bound to SDS micelles vs free in solution. Of these
contacts, the majority which are longer than i + 1 occur
C-terminal to R6 (Figure S1 in the Supporting Information),
implying that this region of apelin-17 is most structured in the
presence of SDS micelles. Eight rounds of structure calculation
were performed with these NOE restraints, with 100 structures
generated in rounds 1-7 and 200 in round 8. Of the 200
structures in the ﬁnal round, the 80 structures with the lowest
total energy were retained as the ﬁnal ensemble with minimal
NOE violations and excellent Ramachandran plot statistics
(Table 2). Evaluation of φ and ψ dihedral angle variation in
terms of both the average deviation and order parameter (S of
Hyberts et al.39) demonstrates a stretch of seven residues from
R6 to K12 with both low average deviation and high S (Figure
4A,B) indicative of structural convergence.35
Independent of this, the ensemble of apelin-17 structures was
superimposed in seven-residue stretches, and the root-mean-
square deviation (rmsd) of backbone atoms was calculated
(Figure 4C). (At superposition lengths of eight residues or
greater, no RMSDs below 0.88 ( 0.2 Å were observed.) For a
seven-residue superposition, the backbone atom rmsd is the
lowest over R6-K12, suggesting that this region is well
converged and mirroring the observation of highly deﬁned φ
and ψ dihedral angles. RMSDs over seven residues indicate
that both the N- and C-terminal regions of apelin-17 are
relatively unstructured in the presence of SDS micelles. Using
Promotif-NMR,38 45 type I and 374 type IV  -turns were
detected in the ﬁnal ensemble (Table 2), with 98% of the type
I  -turns being initiated between R6 and L9. Out of 80
structures, 30 have a type I  -turn initiation at P7. Type IV
 -turns appear to be distributed throughout apelin-17, although
there is a very well-deﬁned type IV  -turn initiated at S10 in
77/80 of the ensemble members (Figure S2 in the Supporting
Information). Paramagnetic relaxation enhancement experiments
(Figure 3) indicate that the structural convergence over R6-K12
is the result of apelin binding to the micelle. In the superposed
structural ensemble, the cationic side-chain atoms of R6 and
R8 also tend to lie on the same face of the peptide, providing
a cationic surface that may interact with the anionic micelle
headgroups (Figure 5B). Since the structure of apelin-17 induced
by anionic micelle binding is consistent between SDS and
LPPG, as observed with CD spectropolarimetry, the NMR
ensemble generated for apelin-17 interacting with SDS is also
representative of the apelin-17 structure when bound to LPPG
micelles.
Upon analysis of superpositions for shorter regions of apelin-
17, an extremely well-converged region of apelin-17 was
observed from M15 to F17 (Figure 5C), with a heavy atom rmsd
of 0.37 ( 0.19 Å and well-converged φ and ψ dihedrals (Figure
4A,B,D). This region is just as converged as some of the
residues between R6 and K12 in terms of both atom positions
and dihedral angles but shows no canonical secondary structur-
ing by Promotif-NMR analysis. Notably, this structural con-
vergence was not observed in apelin-17 in solution at 35 °C,15
indicating induction by apelin-micelle binding even though
M15-F17 are not directly interacting with the micelle.
Implications for Membrane Catalysis of Apelin-APJ
Binding. This study implies that apelin is likely to ﬁt with the
membrane catalysis model put forward by Sargent and Schw-
Figure 3. Retained peak intensity (the error bar is the average
deviation) of apelin-17 in SDS micelles with the indicated amounts of
(A) 5-DSA or 16-DSA or (B) Mn2+ calculated from the intensities of
the 1H-1H TOCSY peaks relative to a reference spectrum.
TABLE 2: Summary of the Restraints Employed for the
Final Ensemble of 80 Retained Structures from 200
Calculated Structuresa
structure
calculation parameter
apelin-17
with SDS
apelin-17
in bufferb
total rounds of NOE reﬁnement 8 12
unique NOE restraints
total 522 285
intraresidue 248 146
sequential 188 108
medium range (|i - j| e 4) 46 22
long range (|i - j| > 4) 0 0
ambiguous 40 9
Ramachandran plot statistics
core 33% 26%
allowed 51% 52%
generously allowed 10% 10%
disallowed 6% 13%
number of type I  -turns 45 9
number of type IV  -turns 274 123
number of type VIII  -turns 6 10
XPLOR-NIH energies (kcal/mol)
total 26.9 ( 2.1 45.14 ( 5.39
NOE 4.6 ( 1.0 0.60 ( 0.49
violations
NOE violations >0.5 Å 0 0
NOE violations of 0.3-0.5 Å 1 0
NOE violations of 0.2-0.3 Å 4 4
a Classiﬁcation of NOE restraints using CYANA, LA Systems,
Tokyo, Japan. XPLOR-NIH energies and average deviations and
violation occurrences calculated using an in-house tcl/Tk script.
Structural statistics for apelin-17 in buffer at 35 °C are shown for
comparison. b Previously reported data.15
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different anionic detergent headgroups, binding to biological
membranes is likely. Furthermore, the structure observed with
apelin bound to SDS micelles should represent the bound state
with a biological membrane. Although a micelle surface is
curved, in this system the curvature is negligible. The radius of
an SDS micelle is ∼20 Å,55 while the binding region of apelin-
17 (R6-L9) spans ∼6.7 Å, or ∼5%, of the micelle circumfer-
ence. Upon membrane interaction, the membrane catalysis
model hypothesizes that a peptide will adopt a conformation
that will accelerate binding to its receptor. The abundant type
I and type IV  -turns which are induced by the anionic
headgroups at the SDS and LPPG micelle surface may increase
apelin’s afﬁnity to the APJ receptor, in line with the suggestion
of Tyndall et al. that  -turns are a ubiquitous motif recognized
by GPCRs.56 However, the high degree of structuring for
M15-F17, although not  -turn in character, is a very striking
micelle-induced structural element that may be even more likely
to allow speciﬁc recognition of apelin by APJ since this portion
of the peptide is not directly membrane-associated and therefore
free to bind. Taken together, the structural changes that occur
to apelin when bound to anionic micelles are likely essential
for initiating interactions with APJ in a membrane. Since both
regions of apelin-17 observed to undergo signiﬁcant confor-
mational restriction in comparison to the remainder of the
peptide reside within the 12-residue functional core retained in
all bioactive apelin isoforms, this binding hypothesis is im-
mediately applicable to the other apelin peptides.
Concluding Remarks. The various active isoforms of apelin
interact similarly with anionic SDS and LPPG micelles but not
with the zwitterionic DPC micelle. Key to this interaction is
the formation of a converged structure from R6 to K12 with
signiﬁcant type I and type IV  -turn initiation between R6 and
L9 and at S10, respectively, while the residues N-terminal to
this region are largely disordered. Part of this converged
structure, R6-L9, interacts most strongly with anionic micelles.
Binding of apelin-17 to SDS also induces structuring of
M15-F17, even though this region is not in direct contact with
the micelle surface. These results, obtained from disparate
biophysical methods, suggest that APJ activation by apelin may
follow the membrane catalysis model, requiring that apelin ﬁrst
bind to the plasma membrane, adopt the observed structure, and
then bind to and activate APJ.
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Figure 4. Analysis of the 80-member NMR-based structural ensemble
of apelin-17 bound to SDS micelles: (A) φ and (B) ψ angle average
deviation (bars) and order parameters39 (lines). Root mean square
deviation (rmsd) calculated iteratively for (C) backbone atom superposi-
tions over seven-residue segments and (D) all heavy atoms over three-
residue superpositions with each bar (the error bar is the average
deviation) plotted at the ﬁrst residue in a superposition.
Figure 5. Structure of apelin-17 bound to an SDS micelle: (A)
superposition of all 80 members of the ﬁnal ensemble of structures
from R6 to K12 (R6-K12 colored blue, remainder green) with P7 and
S10, initiation points of type I and type IV  -turns, respectively,
indicated; (B) zoom of the superposition in (A) (backbone atoms green)
showing cationic side chains of R6 and R8 (blue; all other side chains
red) falling on the same face of apelin-17; (C) superposition of all heavy
atoms of M15-F17 for all 80 ensemble members, with the backbone
shown in blue and side chains colored red.
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